跳至主要内容
临床试验/PACTR202403598655447
PACTR202403598655447尚未招募Unknown

Assessment of Neisseria Gonorrhoeae and Chlamydia Trachomatis Sexually Transmitted Infection Prevalence Among Pregnant Women, Adolescents and Key Populations in Lusaka, Zambia

Global Antibiotics Research and Development Partnership0 个研究点目标入组 1,973 人开始时间: 2024年3月5日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
1,973

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
All

入选标准

  • Pregnant women:
  • 1. Pregnant women aged =15 years attending the ANC clinic in the 1st or 2nd trimester of pregnancy
  • 2. Willingness and ability to provide laboratory specimens for NAAT NG/CT testing
  • 3. Willingness and ability to give written informed assent or consent
  • Adolescent girls and boys:
  • 1. Sexually active girls and boys aged =15 to <19 years
  • 2. Non-pregnant adolescent girls and boys attending the Youth Friendly Corner
  • 3. Willingness and ability to provide laboratory specimens for NAAT NG/CT testing NG/CT testing
  • 4. Willingness and ability to give written informed assent or consent
  • 1. Male and female key population (HRM and FSW) attending the STI clinic =18 years
  • 2. Willingness and ability to provide laboratory specimens for NAAT NG/CT testing
  • 3. Willingness and ability to give written informed consent

排除标准

  • Pregnant women:
  • 1. Previously enrolled study participants (to avoid duplicate sampling)
  • 2. Pregnant women with a high risk of obstetric complications following vaginal swab collection (e.g., history of recurrent pregnancy loss, ongoing spotting/bleeding, threatened abortion, cervical conization, etc.) as per investigator judgment.
  • Adolescent girls and boys:
  • 1. Previously enrolled study participants (to avoid duplicate sampling)
  • 2. Use of any systemic or intravaginal antibiotics for syndromic management of STIs, for vaginal discharge or with activity against NG or CT within 30 days prior to study screening.
  • 1. Previously enrolled study participants (to avoid duplicate sampling)
  • 2. Use of any systemic or intravaginal antibiotics for syndromic management of STIs, for vaginal discharge or with activity against NG or CT within 30 days prior to study screening.

研究者

发起方
Global Antibiotics Research and Development Partnership

相似试验